
Leadership Transition at Houston’s CNS Pharmaceuticals
Houston, December 17, 2025 CNS Pharmaceuticals, Inc., a Houston-based biopharmaceutical company, has announced a significant leadership transition as Rami Levin is appointed the new President and








